<DOC>
	<DOCNO>NCT02509585</DOCNO>
	<brief_summary>Prospective , open-label , within-patient , multi-center study Lymphoseek detection lymph nodes subject know cancer cervix . All subject receive single dose 50 µg Lymphoseek radiolabeled 2 mCi ( 74 MBq ) Tc 99m .</brief_summary>
	<brief_title>A Trial Comparing Pathology Status Lymphoseek®-Identified Sentinel Lymph Nodes Relative Pathological Pathology Status Nonsentinel Lymph Nodes Nodal Staging Subjects With Known Cancer Cervix Who Are Undergoing Lymph Node Dissection</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<mesh_term>Technetium Tc 99m Pentetate</mesh_term>
	<criteria>Subject provide write informed consent HIPAA authorization Has cervical cancer candidate surgical intervention , lymph node dissection part surgical plan . Is least 18 year age time consent Has ECOG performance status Grade 0 2 Has follow International Federation Gynecology Obstetrics ( FIGO ) IA2IIA1staging . Subjects single enlarged/suspicious node PET/CT still consider eligible consistent FIGO guideline . If childbearing potential , subject negative pregnancy test within 48 hour administration Lymphoseek , surgically sterilize , postmenopausal least 1 year The subject preoperative chemotherapy , immunotherapy , radiation therapy within 30 day prior Lymphoseek administration Has previous surgery radiation node basin would involve ILM procedure Has know allergy dextran Is breastfeed pregnant Has receive contrast material ( Xray , MRI ) radiopharmaceutical within 48 hour prior , therapeutic radiopharmaceutical ( e.g. , 131I ) within 10 day , radiopharmaceutical administration within 10 radioactive halflives administration Lymphoseek administration substance plan within 7 day Lymphoseek administration Is schedule surgery and/or another invasive procedure primary surgical intervention within 3 day Lymphoseek administration Has receive investigational product within 30 day prior Lymphoseek administration</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>